American Journal of Respiratory and Critical Care Medicine

Valentine Mismetti, Salim Si-Mohamed, Vincent Cottin. (2024) Interstitial Lung Disease Associated with Systemic Sclerosis. Seminars in Respiratory and Critical Care Medicine 401.
Online publication date: 7-May-2024.
Crossref
Francesco Del Galdo, Elizabeth R. Volkmann, Robert Lafyatis. 2024. Biomarkers in Systemic Sclerosis. Scleroderma, 247-263.
Crossref
Athol U. Wells. 2024. Overview of Lung Involvement. Scleroderma, 369-375.
Crossref
Muriel Elhai, Bruno Crestani, Maria-Sinziana Muraru-Carbrune, Yannick Allanore. 2024. Treatment of Interstitial Lung Disease in Systemic Sclerosis. Scleroderma, 401-419.
Crossref
Anna-Maria Hoffmann-Vold, Kristin B. Highland, Elisabeth Bendstrup. 2024. Clinical Assessment of ILD. Scleroderma, 377-387.
Crossref
Athol U. Wells, George A. Margaritopoulos, Katerina M. Antoniou, Andrew G. Nicholson. 2023. Systemic Sclerosis and the Lung. Orphan Lung Diseases, 193-205.
Crossref
Ami A. Shah, Janet E. Pope, Dinesh Khanna, Maureen Mayes, Virginia Steen, Christopher Denton. 2023. Systemic Sclerosis (Scleroderma) and Raynaud’s Phenomenon. A Clinician's Pearls & Myths in Rheumatology, 111-132.
Crossref
A. Lescoat, S. Jouneau, Y. Uzunhan, P. Jégo, V. Cottin, E. Hachulla. (2022) Pneumopathie interstitielle diffuse associée à la sclérodermie systémique : prise en charge diagnostique et thérapeutique à la lumière des essais thérapeutiques récents. La Revue de Médecine Interne 43:6, 365-374.
Online publication date: 1-Jun-2022.
Crossref
Yusuke Yoshida, Tomohiro Sugimoto, Yohei Hosokawa, Harumichi Suma, Hiroki Kobayashi, Michinori Ishitoku, Hiroki Kohno, Tadahiro Tokunaga, Hirofumi Watanabe, Sho Mokuda, Takaki Nojima, Shintaro Hirata, Eiji Sugiyama. (2022) C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoids. Modern Rheumatology 32:1, 141-148.
Online publication date: 15-Apr-2021.
Crossref
Corrado Campochiaro, Cosimo Bruni, Sara Tomassetti, Lorenzo Dagna, Marco Matucci-Cerinic. 2022. Lung involvement in systemic sclerosis. The Lung in Autoimmune Diseases, 73-103.
Crossref
Madelon C. Vonk, Vanessa Smith, Petros P. Sfikakis, Maurizio Cutolo, Francesco del Galdo, James R. Seibold. (2021) Pharmacological treatments for SSc-ILD: Systematic review and critical appraisal of the evidence. Autoimmunity Reviews 20:12, 102978.
Online publication date: 1-Dec-2021.
Crossref
Sérgio Oliveira da Silva, Adriane Souza da Paz, Isla Miranda Vidal Cavalcante Farias, Damille Sandes Moreira, Marianna Alegro Fontes Ribeiro, Tatiana Senna Galvão Nonato Alves, Antônio Carlos Moreira Lemos, Mittermayer Barreto Santiago. (2021) Bronchoalveolar Lavage in Systemic Sclerosis Patients: A Systematic Review. Current Rheumatology Reviews 17:2, 176-183.
Online publication date: 19-May-2021.
Crossref
Mary M. Buckley, C. Egla Rabinovich. (2021) Pulmonary Manifestations of Rheumatic Diseases in Children. Pediatric Clinics of North America 68:1, 147-166.
Online publication date: 1-Feb-2021.
Crossref
Sara Tomassetti, Thomas V. Colby, Athol U. Wells, Venerino Poletti, Ulrich Costabel, Marco Matucci-Cerinic. (2021) Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do?. Therapeutic Advances in Musculoskeletal Disease 13, 1759720X2110596.
Online publication date: 8-Dec-2021.
Crossref
Niranjan Jeganathan, Matheni Sathananthan. (2020) Connective Tissue Disease-Related Interstitial Lung Disease: Prevalence, Patterns, Predictors, Prognosis, and Treatment. Lung 198:5, 735-759.
Online publication date: 11-Aug-2020.
Crossref
. (2020) Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine 201:6, 650-660.
Online publication date: 13-Mar-2020.
Abstract | Full Text | PDF (1841 KB) | Supplemental Material 
Apostolos Perelas, Richard M Silver, Andrea V Arrossi, Kristin B Highland. (2020) Systemic sclerosis-associated interstitial lung disease. The Lancet Respiratory Medicine 8:3, 304-320.
Online publication date: 1-Mar-2020.
Crossref
Aparna Das, Anupam Kumar, Andrea Valeria Arrossi, Subha Ghosh, Kristin B. Highland. (2019) Scleroderma-related interstitial lung disease: principles of management. Expert Review of Respiratory Medicine 13:4, 357-367.
Online publication date: 11-Feb-2019.
Crossref
Abhishek Gadre, Kristin B. Highland. (2018) Connective Tissue Related Interstitial Lung Disease. Current Pulmonology Reports 7:4, 133-148.
Online publication date: 8-Oct-2018.
Crossref
P. Xanthouli, W. Hermann, N. Hunzelmann, M. Kreuter. (2018) Sklerodermie-assoziierte interstitielle Lungenerkrankungen. Der Pneumologe 15:6, 383-395.
Online publication date: 1-Aug-2018.
Crossref
Dilli Ram Poudel, Divya Jayakumar, Abhijeet Danve, Shiv Tej Sehra, Chris T. Derk. (2018) Determinants of mortality in systemic sclerosis: a focused review. Rheumatology International 38:10, 1847-1858.
Online publication date: 7-Nov-2017.
Crossref
W. M. T. van den Hombergh, S. O. Simons, E. Teesselink, H. K. A. Knaapen-Hans, F. H. J. van den Hoogen, J. Fransen, M. C. Vonk. (2018) Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function. Clinical Rheumatology 37:10, 2715-2722.
Online publication date: 10-Jul-2018.
Crossref
Melissa Caron, Sabrina Hoa, Marie Hudson, Kevin Schwartzman, Russell Steele. (2018) Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease. European Respiratory Review 27:148, 170102.
Online publication date: 15-May-2018.
Crossref
Yoshihide Asano, Masatoshi Jinnin, Yasushi Kawaguchi, Masataka Kuwana, Daisuke Goto, Shinichi Sato, Kazuhiko Takehara, Masaru Hatano, Manabu Fujimoto, Naoki Mugii, Hironobu Ihn. (2018) Diagnostic criteria, severity classification and guidelines of systemic sclerosis. The Journal of Dermatology 45:6, 633-691.
Online publication date: 23-Apr-2018.
Crossref
Peter M. George, Athol U. Wells. (2018) Disease staging and sub setting of interstitial lung disease associated with systemic sclerosis: impact on therapy. Expert Review of Clinical Immunology 14:2, 127-135.
Online publication date: 20-Jan-2018.
Crossref
Hayley Barnes, Anne E Holland, Glen P Westall, Nicole SL Goh, Ian N Glaspole, . (2018) Cyclophosphamide for connective tissue disease-associated interstitial lung disease. Cochrane Database of Systematic Reviews 2018:1.
Online publication date: 3-Jan-2018.
Crossref
Danielle Antin-Ozerkis, Ami Rubinowitz, Janine Evans, Robert J. Homer, Richard A. Matthay. 2018. Interstitial Lung Disease in the Connective Tissue Diseases. Interstitial Lung Disease, 157-185.
Crossref
Gregory J. Keir, Richard M. Silver, Athol U. Wells. 2017. Clinical Assessment of Lung Disease. Scleroderma, 363-373.
Crossref
Kevin K. Brown, Vincent Cottin. 2017. Treatment of Interstitial Lung Disease. Scleroderma, 375-383.
Crossref
Jacob M. van Laar, Robert W. Simms. 2017. Immunomodulatory, Immunoablative, and Biologic Therapies. Scleroderma, 567-582.
Crossref
. (2016) Treatment of Systemic Sclerosis–related Interstitial Lung Disease: A Review of Existing and Emerging Therapies. Annals of the American Thoracic Society 13:11, 2045-2056.
Online publication date: 10-Nov-2016.
Abstract | Full Text | PDF (662 KB) | Supplemental Material 
Z. Aydi, I. Rachdi, B. Ben Dhaou, M. Dridi, F. Daoud, L. Baili, F. Boussema. (2016) Particularités épidémiologiques, cliniques et évolutives des pneumopathies interstitielles au cours de la sclérodermie systémique. Revue de Pneumologie Clinique 72:2, 122-128.
Online publication date: 1-Apr-2016.
Crossref
Mike O. Becker, Gabriela Riemekasten. (2016) Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course. Expert Review of Clinical Immunology 12:2, 115-135.
Online publication date: 2-Dec-2015.
Crossref
Tamera J. Corte, Roland M. Du Bois, Athol U. Wells. 2016. Connective Tissue Diseases. Murray and Nadel's Textbook of Respiratory Medicine, 1165-1187.e14.
Crossref
Katja Lakota, Mary Carns, Sofia Podlusky, Katjusa Mrak-Poljsak, Monique Hinchcliff, Jungwha Lee, Matija Tomsic, Snezna Sodin-Semrl, John Varga, Shervin Assassi. (2015) Serum Amyloid A Is a Marker for Pulmonary Involvement in Systemic Sclerosis. PLOS ONE 10:1, e0110820.
Online publication date: 28-Jan-2015.
Crossref
Paul F. Dellaripa, Ivan O. Rosas. 2015. The lung in rheumatic disease. Rheumatology, 274-278.
Crossref
Hidekata Yasuoka. (2015) Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9s1, CCRPM.S23315.
Online publication date: 19-Jan-2016.
Crossref
Athol U. Wells, George A. Margaritopoulos, Katerina M. Antoniou, Andrew G. Nicholson. 2015. Interstitial Lung Disease in Systemic Sclerosis. Orphan Lung Diseases, 379-390.
Crossref
T. Hua-Huy, S. Rivière, K.P. Tiev, A.T. Dinh-Xuan. (2014) Intérêts des explorations fonctionnelles respiratoires et des études des biomarqueurs dans le diagnostic et le suivi évolutif de la pneumopathie interstitielle diffuse dans la sclérodermie systémique. Revue de Pneumologie Clinique 70:6, 335-342.
Online publication date: 1-Dec-2014.
Crossref
Athol U. Wells, Christopher P. Denton. (2014) Interstitial lung disease in connective tissue disease—mechanisms and management. Nature Reviews Rheumatology 10:12, 728-739.
Online publication date: 30-Sep-2014.
Crossref
Angelo De Lauretis, Elisabetta A. Renzoni. (2014) Molecular Biomarkers in Interstitial Lung Diseases. Molecular Diagnosis & Therapy 18:5, 505-522.
Online publication date: 17-Jun-2014.
Crossref
Athol U. Wells. (2014) Interstitial lung disease in systemic sclerosis. La Presse Médicale 43:10, e329-e343.
Online publication date: 1-Oct-2014.
Crossref
Lara Zafrani, Virginie Lemiale, Nathanael Lapidus, Gwenael Lorillon, Benoît Schlemmer, Elie Azoulay, Shervin Assassi. (2014) Acute Respiratory Failure in Critically Ill Patients with Interstitial Lung Disease. PLoS ONE 9:8, e104897.
Online publication date: 12-Aug-2014.
Crossref
Kiet Phong Tiev, Sébastien Rivière, Thong Hua-Huy, Jean Cabane, Anh Tuan Dinh-Xuan. (2014) Exhaled NO predicts cyclophosphamide response in scleroderma-related lung disease. Nitric Oxide 40, 17-21.
Online publication date: 1-Aug-2014.
Crossref
Tiffany A. Winstone, Deborah Assayag, Pearce G. Wilcox, James V. Dunne, Cameron J. Hague, Jonathon Leipsic, Harold R. Collard, Christopher J. Ryerson. (2014) Predictors of Mortality and Progression in Scleroderma-Associated Interstitial Lung Disease. Chest 146:2, 422-436.
Online publication date: 1-Aug-2014.
Crossref
Aryeh Fischer, Kevin K. Brown. 2014. Evaluation of Lung Disease in Patients with Connective Tissue Disease. Pulmonary Manifestations of Rheumatic Disease, 13-23.
Crossref
Nargues Weir, Virginia Steen. 2014. Interstitial Lung Disease in Systemic Sclerosis. Pulmonary Manifestations of Rheumatic Disease, 37-47.
Crossref
Russell Chapin, Faye N. Hant. (2013) Imaging of Scleroderma. Rheumatic Disease Clinics of North America 39:3, 515-546.
Online publication date: 1-Aug-2013.
Crossref
Roger Hesselstrand, Marie Wildt, Gracijela Bozovic, Annika Andersson-Sjöland, Kristofer Andréasson, Agneta Scheja, Gunilla Westergren-Thorsson, Leif Bjermer, Dirk M. Wuttge. (2013) Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis. Respiratory Medicine 107:7, 1079-1086.
Online publication date: 1-Jul-2013.
Crossref
Kiet Phong Tiev, Thong Hua-Huy, Sébastien Rivière, Nhat-Nam Le-Dong, Michel Febvre, Jean Cabane, Anh Tuan Dinh-Xuan. (2013) High alveolar concentration of nitric oxide is associated with alveolitis in scleroderma. Nitric Oxide 28, 65-70.
Online publication date: 1-Jan-2013.
Crossref
Arthur C. Theodore, Chi-Hong Tseng, Ning Li, Robert M. Elashoff, Donald P. Tashkin. (2012) Correlation of Cough With Disease Activity and Treatment With Cyclophosphamide in Scleroderma Interstitial Lung Disease. Chest 142:3, 614-621.
Online publication date: 1-Sep-2012.
Crossref
Aryeh Fischer, Roland du Bois. (2012) Interstitial lung disease in connective tissue disorders. The Lancet 380:9842, 689-698.
Online publication date: 1-Aug-2012.
Crossref
Danielle Antin-Ozerkis, Ami Rubinowitz, Janine Evans, Robert J. Homer, Richard A. Matthay. (2012) Interstitial Lung Disease in the Connective Tissue Diseases. Clinics in Chest Medicine 33:1, 123-149.
Online publication date: 1-Mar-2012.
Crossref
C. Egla Rabinovich. (2012) Pulmonary Complications of Childhood Rheumatic Disease. Paediatric Respiratory Reviews 13:1, 29-36.
Online publication date: 1-Mar-2012.
Crossref
Dionisio Pérez Campos, Miguel Estévez Del Toro, Aisa Peña Casanovas, Pedro Pablo González Rojas, Lisvenia Morales Sánchez, Ángela Rosa Gutiérrez Rojas. (2012) ¿Son necesarias las dosis elevadas de prednisona para el tratamiento de la neumopatía intersticial en la esclerosis sistémica?. Reumatología Clínica 8:2, 58-62.
Online publication date: 1-Mar-2012.
Crossref
Dionisio Pérez Campos, Miguel Estévez Del Toro, Aisa Peña Casanovas, Pedro Pablo González Rojas, Lisvenia Morales Sánchez, Ángela Rosa Gutiérrez Rojas. (2012) Are High Doses of Prednisone Necessary for Treatment of Interstitial Lung Disease in Systemic Sclerosis?. Reumatología Clínica (English Edition) 8:2, 58-62.
Online publication date: 1-Mar-2012.
Crossref
2012. Kapitel E1 Literaturverzeichnis zu Peter, Pichler, Müller-Ladner (Hrsg.): Klinische Immunologie. Klinische Immunologie, e1-e80.
Crossref
Sara Sánchez-Vidaurre, Carmen Pilar Simeón, Maria Jesús Cruz, Vicente Fonollosa, Miguel Vilardell, Ferran Morell, Xavier Muñoz. (2012) Latent Pulmonary Inflammation in Patients With Systemic Sclerosis. Archivos de Bronconeumología (English Edition) 48:1, 8-13.
Online publication date: 1-Jan-2012.
Crossref
Sara Sánchez-Vidaurre, Carmen Pilar Simeón, Maria Jesús Cruz, Vicente Fonollosa, Miguel Vilardell, Ferran Morell, Xavier Muñoz. (2012) Inflamación pulmonar latente en pacientes con esclerosis sistémica. Archivos de Bronconeumología 48:1, 8-13.
Online publication date: 1-Jan-2012.
Crossref
Dinesh Khanna, Donald P. Tashkin. 2012. Treatment of Interstitial Lung Disease. Scleroderma, 421-427.
Crossref
Athol U. Wells, Jonathan Goldin. 2012. Computerized Tomography of Interstitial Lung Disease. Scleroderma, 415-419.
Crossref
Aryeh Fischer, Roland M. du Bois. 2012. A Practical Approach to Connective Tissue Disease-Associated Lung Disease. Diffuse Lung Disease, 217-237.
Crossref
Gregory J. Keir, Richard M. Silver, Athol U. Wells. 2012. Clinical Assessment of Lung Disease. Scleroderma, 403-413.
Crossref
Jacob M. van Laar. 2012. Immunomodulatory Therapies. Scleroderma, 577-589.
Crossref
Maria De Santis, Silvia Laura Bosello, Giusy Peluso, Michela Pinnelli, Stefano Alivernini, Gaetano Zizzo, Mario Bocci, Annunziata Capacci, Giuseppe La Torre, Alice Mannocci, Gabriella Pagliari, Francesco Varone, Roberto Pistelli, Francesco Maria Danza, Gianfranco Ferraccioli. (2012) Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease. The Clinical Respiratory Journal 6:1, 9-17.
Online publication date: 25-Nov-2010.
Crossref
C. Egla Rabinovich. (2011) Challenges in the diagnosis and treatment of juvenile systemic sclerosis. Nature Reviews Rheumatology 7:11, 676-680.
Online publication date: 11-Oct-2011.
Crossref
Dinesh Khanna, Chi-Hong Tseng, Niloofar Farmani, Virginia Steen, Daniel E. Furst, Philip J. Clements, Michael D. Roth, Jonathan Goldin, Robert Elashoff, James R. Seibold, Rajeev Saggar, Donald P. Tashkin. (2011) Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: Analysis of the Scleroderma Lung Study Placebo Group. Arthritis & Rheumatism 63:10, 3078-3085.
Online publication date: 27-Sep-2011.
Crossref
Joshua J Solomon, Kevin K Brown. (2011) Management of interstitial lung disease in systemic sclerosis. International Journal of Clinical Rheumatology 6:5, 503-515.
Online publication date: 1-Oct-2011.
Crossref
Stefania Volpinari, Renato La Corte, Stefano Bighi, Franco Ravenna, Napoleone Prandini, Andrea Lo Monaco, Francesco Trotta. (2011) Bronchoalveolar lavage in systemic sclerosis with lung involvement: role and correlations with functional, radiological and scintigraphic parameters. Rheumatology International 31:9, 1183-1188.
Online publication date: 30-Mar-2010.
Crossref
Michael D. Roth, Chi‐Hong Tseng, Philip J. Clements, Daniel E. Furst, Donald P. Tashkin, Jonathan G. Goldin, Dinesh Khanna, Eric C. Kleerup, Ning Li, David Elashoff, Robert M. Elashoff, . (2011) Predicting treatment outcomes and responder subsets in scleroderma‐related interstitial lung disease. Arthritis & Rheumatism 63:9, 2797-2808.
Online publication date: 31-Aug-2011.
Crossref
Herbert Y. Reynolds. (2011) Bronchoalveolar Lavage and Other Methods to Define the Human Respiratory Tract Milieu in Health and Disease. Lung 189:2, 87-99.
Online publication date: 25-Feb-2011.
Crossref
Jérôme Le Pavec, David Launay, Stephen C. Mathai, Paul M. Hassoun, Marc Humbert. (2011) Scleroderma Lung Disease. Clinical Reviews in Allergy & Immunology 40:2, 104-116.
Online publication date: 12-Jan-2010.
Crossref
Y. Uzunhan. (2011) Pneumopathie interstitielle diffuse chronique avec hyperéosinophilie au LBA (Interprétation d’une hyperéosinophilie au LBA). Revue des Maladies Respiratoires Actualités 3:2, 77-82.
Online publication date: 1-Mar-2011.
Crossref
Aryeh Fischer, Roland M. du Bois. 2011. Lung. Systemic Lupus Erythematosus, 847-864.
Crossref
Paul F. Dellaripa, Ivan O. Rosas. 2011. The lung in rheumatic disease. Rheumatology, 315-320.e2.
Crossref
Paul M. Hassoun. (2011) Lung involvement in systemic sclerosis. La Presse Médicale 40:1, e25-e39.
Online publication date: 1-Jan-2011.
Crossref
Otylia Kowal-Bielecka, Krzysztof Kowal, Elzbieta Chyczewska. (2010) Utility of Bronchoalveolar Lavage in Evaluation of Patients with Connective Tissue Diseases. Clinics in Chest Medicine 31:3, 423-431.
Online publication date: 1-Sep-2010.
Crossref
Faye N. Hant, Laura B. Herpel, Richard M. Silver. (2010) Pulmonary Manifestations of Scleroderma and Mixed Connective Tissue Disease. Clinics in Chest Medicine 31:3, 433-449.
Online publication date: 1-Sep-2010.
Crossref
Otylia Kowal-Bielecka, Krzysztof Kowal, Kristin B. Highland, Richard M. Silver. (2010) Bronchoalveolar Lavage Fluid in Scleroderma Interstitial Lung Disease: Technical Aspects and Clinical Correlations: Review of the Literature. Seminars in Arthritis and Rheumatism 40:1, 73-88.
Online publication date: 1-Aug-2010.
Crossref
THONG HUA-HUY, KIET PHONG TIEV, CHRISTIANE CHÉREAU, SY DUONG-QUY, JEAN CABANE, ANH TUAN DINH-XUAN. (2010) Increased Alveolar Concentration of Nitric Oxide Is Related to Serum-induced Lung Fibroblast Proliferation in Patients with Systemic Sclerosis. The Journal of Rheumatology 37:8, 1680-1687.
Online publication date: 1-Jul-2010.
Crossref
Dinesh Khanna, Christopher P. Denton. (2010) Evidence-based management of rapidly progressing systemic sclerosis. Best Practice & Research Clinical Rheumatology 24:3, 387-400.
Online publication date: 1-Jun-2010.
Crossref
S. Harari, A. Caminati. (2010) Update on diffuse parenchymal lung disease. European Respiratory Review 19:116, 97-108.
Online publication date: 31-May-2010.
Crossref
Diane Strollo, Jonathan Goldin. (2010) Imaging Lung Disease in Systemic Sclerosis. Current Rheumatology Reports 12:2, 156-161.
Online publication date: 16-Mar-2010.
Crossref
M Colaci, M Sebastiani, D Giuggioli, A Manfredi, P Spagnolo, F Luppi, L Richeldi, C Ferri. (2010) Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. Scandinavian Journal of Rheumatology 39:2, 155-159.
Online publication date: 11-Jan-2010.
Crossref
Laura K. Hummers. (2010) The Current State of Biomarkers in Systemic Sclerosis. Current Rheumatology Reports 12:1, 34-39.
Online publication date: 27-Jan-2010.
Crossref
Brent W. Kinder. 2010. Scleroderma Lung Disease. Molecular Basis of Pulmonary Disease, 409-419.
Crossref
Tamera J. Corte, Roland M. du Bois, Athol U. Wells. 2010. The Lungs and Connective Tissue Diseases. Murray and Nadel's Textbook of Respiratory Medicine, 1398-1426.
Crossref
Nicole S. L. Goh. (2009) Connective Tissue Disease and the Lung. Clinical Pulmonary Medicine 16:6, 309-314.
Online publication date: 1-Nov-2009.
Crossref
Jonathan Goldin, Robert Elashoff, Hyun J. Kim, Xaiohong Yan, David Lynch, Diane Strollo, Michael D. Roth, Philip Clements, Daniel E. Furst, Dinesh Khanna, Srainnapha Vasunilashorn, Gang Li, Donald P. Tashkin. (2009) Treatment of Scleroderma-Interstitial Lung Disease With Cyclophosphamide Is Associated With Less Progressive Fibrosis on Serial Thoracic High-Resolution CT Scan Than Placebo. Chest 136:5, 1333-1340.
Online publication date: 1-Nov-2009.
Crossref
Galina S. Bogatkevich, Anna Ludwicka‐Bradley, Richard M. Silver. (2009) Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts. Arthritis & Rheumatism 60:11, 3455-3464.
Online publication date: 29-Oct-2009.
Crossref
Herbert Y Reynolds. (2009) Present status of bronchoalveolar lavage in interstitial lung disease. Current Opinion in Pulmonary Medicine 15:5, 479-485.
Online publication date: 1-Sep-2009.
Crossref
(2009) Current World Literature. Current Opinion in Pulmonary Medicine 15:5, 521-527.
Online publication date: 1-Sep-2009.
Crossref
Emer Kelly, Jonathan D. Dodd, Michael P. Keane. (2009) Mycophenolate in the Treatment of Scleroderma-Associated Interstitial Lung Disease and Other Collagen Vascular Disease-Related Interstitial Lung Disease. Clinical Pulmonary Medicine 16:4, 194-198.
Online publication date: 1-Jul-2009.
Crossref
Karen Au, Dinesh Khanna, Philip J. Clements, Daniel E. Furst, Donald P. Tashkin. (2009) Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: Lessons from clinical trials. Current Rheumatology Reports 11:2, 111-119.
Online publication date: 22-Mar-2009.
Crossref
Kiet Phong Tiev, Nhat-Nam Le-Dong, Sy Duong-Quy, Thông Hua-Huy, Jean Cabane, Anh Tuan Dinh-Xuan. (2009) Exhaled nitric oxide, but not serum nitrite and nitrate, is a marker of interstitial lung disease in systemic sclerosis. Nitric Oxide 20:3, 200-206.
Online publication date: 1-Apr-2009.
Crossref
FAYE N. HANT, ANNA LUDWICKA-BRADLEY, HE-JING WANG, NING LI, ROBERT ELASHOFF, DONALD P. TASHKIN, RICHARD M. SILVER. (2009) Surfactant Protein D and KL-6 as Serum Biomarkers of Interstitial Lung Disease in Patients with Scleroderma. The Journal of Rheumatology 36:4, 773-780.
Online publication date: 13-Mar-2009.
Crossref
. (2009) Update in Diffuse Parenchymal Lung Disease 2008. American Journal of Respiratory and Critical Care Medicine 179:6, 439-444.
Online publication date: 20-Dec-2012.
First Page | Full Text | PDF (97 KB) 
Aryeh Fischer, Kevin K. Brown, Stephen K. Frankel. (2009) Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease. Clinical Pulmonary Medicine 16:2, 74-80.
Online publication date: 1-Mar-2009.
Crossref
Alan N. Brown, Charlie Strange. 2009. Connective Tissue Disease and Vasculitis-Associated Interstitial Lung Disease. Pulmonary Arterial Hypertension and Interstitial Lung Diseases, 159-175.
Crossref
Janet E. Pope, Philip J. Clements, Daniel E. Furst, Laura K. Hummers, Dinesh Khanna, Maureen D. Mayes, Thomas Medsger, James Seibold, Virginia Steen. 2009. Systemic Sclerosis (Scleroderma) and Raynaud’s Phenomenon. A Clinician's Pearls and Myths in Rheumatology, 77-95.
Crossref
C. Egla Rabinovich, Edward Fels, Joseph Shanahan, J. Marc Majure, Thomas M. Murphy. 2009. Pulmonary Manifestations of Rheumatoid Diseases. Pulmonary Manifestations of Pediatric Diseases, 201-240.
Crossref
KM Antoniou, AU Wells. (2008) Scleroderma lung disease: evolving understanding in light of newer studies. Current Opinion in Rheumatology 20:6, 686-691.
Online publication date: 1-Nov-2008.
Crossref
(2008) Current World Literature. Current Opinion in Rheumatology 20:6, 729-735.
Online publication date: 1-Nov-2008.
Crossref
R. M. Silver, A. U. Wells. (2008) Histopathology and bronchoalveolar lavage. Rheumatology 47:Supplement 5, v62-v64.
Online publication date: 1-Oct-2008.
Crossref
Y. Uzunhan. (2008) Pneumopathies interstitielles diffuses (PID) associées aux connectivites. Revue des Maladies Respiratoires 25, 69-76.
Online publication date: 1-Sep-2008.
Crossref
Jonathan G. Goldin, David A. Lynch, Diane C. Strollo, Robert D. Suh, Dean E. Schraufnagel, Philip J. Clements, Robert M. Elashoff, Daniel E. Furst, Sarinnapha Vasunilashorn, Michael F. McNitt-Gray, Mathew S. Brown, Michael D. Roth, Donald P. Tashkin. (2008) High-Resolution CT Scan Findings in Patients With Symptomatic Scleroderma-Related Interstitial Lung Disease. Chest 134:2, 358-367.
Online publication date: 1-Aug-2008.
Crossref
N. Hunzelmann, E. Genth, T. Krieg, M. Meurer, I. Melchers, P. Moinzadeh, C. Pfeiffer, G. Riemekasten, E. Schulze-Lohoff, C. Sunderkoetter, U. Müller-Ladner. (2008) Organspezifische Diagnostik von Patienten mit systemischer Sklerodermie. Zeitschrift für Rheumatologie 67:4, 334-340.
Online publication date: 18-Apr-2008.
Crossref
. (2008) Prognostic Significance of Bronchoalveolar Lavage Cellular Analysis in Scleroderma Lung Disease. American Journal of Respiratory and Critical Care Medicine 177:11, 1292-1293.
Online publication date: 20-Dec-2012.
First Page | Full Text | PDF (48 KB) 
. (2008) Prognostic Significance of Bronchoalveolar Lavage Cellular Analysis in Scleroderma Lung Disease. American Journal of Respiratory and Critical Care Medicine 177:11, 1293-1293.
Online publication date: 20-Dec-2012.
First Page | Full Text | PDF (36 KB) 
. (2008) Scleroderma Lung Disease. American Journal of Respiratory and Critical Care Medicine 177:11, 1178-1179.
Online publication date: 20-Dec-2012.
First Page | Full Text | PDF (45 KB) 
. (2008) Bronchoalveolar Cellular Analysis in Scleroderma Lung Disease. American Journal of Respiratory and Critical Care Medicine 177:1, 2-3.
Online publication date: 20-Dec-2012.
First Page | Full Text | PDF (48 KB) 
A. U. Wells, V. Steen, G. Valentini. (2006) Pulmonary complications: one of the most challenging complications of systemic sclerosis. Rheumatology 48:suppl_3, iii40-iii44.
Online publication date: 28-May-2009.
Crossref

Related

No related items
American Journal of Respiratory and Critical Care Medicine
177
1

Click to see any corrections or updates and to confirm this is the authentic version of record